Lahoz Carlos, Valdivielso Pedro, González-Alegre María Teresa, García-Iglesias María Francisca, Estirado Eva, Mostaza José M
Unidad de Lípidos y Riesgo Vascular, Hospital Carlos III, Madrid, España.
Servicio de Medicina Interna, Hospital Virgen de la Victoria, Málaga, España.
Clin Investig Arterioscler. 2015 Sep-Oct;27(5):221-5. doi: 10.1016/j.arteri.2015.02.002. Epub 2015 Mar 12.
Survivors of cancer have a shorter survival in the long term partly due to the increase in cardiovascular diseases (CVD). Some chemotherapy drugs, thoracic and cranial radiotherapy and above all the transplantation of hematopoietic cells are associated with an increase in the incidence of cardiovascular events compared with general population. Some of these treatments favor the development of a metabolic syndrome that could be the intermediary between these treatments and the development of CVD. It is recommended for cancer survivors to promote healthy lifestyles and the strict control of cardiovascular risk factors.
癌症幸存者的长期生存率较低,部分原因是心血管疾病(CVD)的增加。与普通人群相比,一些化疗药物、胸部和头部放疗,尤其是造血细胞移植与心血管事件发生率的增加有关。这些治疗中的一些会促进代谢综合征的发展,而代谢综合征可能是这些治疗与心血管疾病发展之间的中间环节。建议癌症幸存者促进健康的生活方式并严格控制心血管危险因素。